CGH analysis of secondary genetic changes in Ewing tumors:
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 130 (1) , 57-61
- https://doi.org/10.1016/s0165-4608(01)00454-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical Correlations of Genetic Changes by Comparative Genomic Hybridization in Ewing Sarcoma and Related TumorsCancer Genetics and Cytogenetics, 1999
- Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumorsGenes, Chromosomes and Cancer, 1999
- Recurrent Chromosomal Imbalances Detected in Biopsy Material from Oral Premalignant and Malignant Lesions by Combined Tissue Microdissection, Universal DNA Amplification, and Comparative Genomic HybridizationThe American Journal of Pathology, 1998
- Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique.Journal of Clinical Oncology, 1998
- EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.Journal of Clinical Oncology, 1998
- Frequency and Implications of Chromosome 8 and 12 Gains in Ewing SarcomaCancer Genetics and Cytogenetics, 1998
- Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridizationBritish Journal of Cancer, 1997
- Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridizationGenes, Chromosomes and Cancer, 1997
- Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, Chromosomes and Cancer, 1994
- Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplificationHuman Molecular Genetics, 1993